After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Add Yahoo as a preferred source to see more of our stories on Google. Nov. 14—(StatePoint) If you're one of the 35 million people living with a chronic lung disease in the United States, the form of ...
Yupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet nebulizer. It’s typically ...
The recent Food and Drug Administration (FDA) approval of ensifentrine marks the first new treatment for patients with persistent chronic obstructive pulmonary disease (COPD) in more than a decade, ...
Verona Pharma recently got approval for ensifentrine in COPD. Ensifentrine has a differentiated MoA and superior safety profile. Despite a diverse market, Verona will find its own place here. Verona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results